Pretreatment predictors of very poor clinical outcomes in medium vessel occlusion stroke patients treated with mechanical thrombectomy
- 19 August 2024
- journal article
- research article
- Published by SAGE Publications in International Journal of Stroke
- Vol. 19 (10) , 1123-1133
Abstract
Background: Acute ischemic stroke (AIS) from primary medium vessel occlusions (MeVO) is a prevalent condition associated with substantial morbidity and mortality. Despite the common use of mechanical thrombectomy (MT) in AIS, predictors of poor outcomes in MeVO remain poorly characterized. Methods: In this prospectively collected, retrospectively reviewed, multicenter, multinational study, data from the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry were analyzed. The study included 1568 patients from 37 academic centers across North America, Asia, and Europe, treated with MT, with or without intravenous tissue plasminogen activator (IVtPA), between September 2017 and July 2021. Results: Among the 1568 patients, 347 (22.2%) experienced very poor outcomes (modified Rankin score (mRS), 5–6). Key predictors of poor outcomes were advanced age (odds ratio (OR): 1.03; 95% confidence interval (CI): 1.02 to 1.04; p < 0.001), higher baseline National Institutes of Health Stroke Scale (NIHSS) scores (OR: 1.07; 95% CI: 1.05 to 1.10; p < 0.001), pre-operative glucose levels (OR: 1.01; 95% CI: 1.00 to 1.02; p < 0.001), and a baseline mRS of 4 (OR: 2.69; 95% CI: 1.25 to 5.82; p = 0.011). The multivariable model demonstrated good predictive accuracy with an area under the receiver-operating characteristic (ROC) curve of 0.76. Conclusions: This study demonstrates that advanced age, higher NIHSS scores, elevated pre-stroke mRS, and pre-operative glucose levels significantly predict very poor outcomes in AIS-MeVO patients who received MT. These findings highlight the importance of a comprehensive risk assessment in primary MeVO patients for personalized treatment strategies. However, they also suggest a need for cautious patient selection for endovascular thrombectomy. Further prospective studies are needed to confirm these findings and explore targeted therapeutic interventions.Keywords
This publication has 45 references indexed in Scilit:
- Pretreatment parameters associated with hemorrhagic transformation among successfully recanalized medium vessel occlusionsJournal of Neurology, 2023
- Incidence and predictors of poor functional outcome despite complete recanalisation following endovascular thrombectomy for acute ischaemic strokeJournal of Stroke and Cerebrovascular Diseases, 2023
- Diffusion-Weighted Imaging Hyperintensities in Acute and Subacute-Phase Intracerebral HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2022
- Endovascular Thrombectomy for Distal Medium Vessel Occlusions of the Middle Cerebral Artery: A Safe and Effective ProcedureWorld Neurosurgery, 2022
- Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic strokeBrain Hemorrhages, 2021
- Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INRJournal of Stroke and Cerebrovascular Diseases, 2021
- Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion StrokeJAMA Neurology, 2021
- Mechanical Thrombectomy of Distal Occlusions Using a Direct Aspiration First Pass Technique Compared with New Generation of Mini-0.017 Microcatheter Compatible–Stent Retrievers: A Meta-AnalysisWorld Neurosurgery, 2020
- Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature reviewJournal of Diabetes Investigation, 2018
- Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic StrokeJAMA, 2018